Delivery Order SPE2DB24D8001-SPE2DB24FKZCL
Award Date
9/25/24
Potential Completion Date
9/26/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB24D8001|SPE2DB25FKZLY, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, primarily to support U.S. Armed Forces medical operations. The contract is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which is part of the DLA Troop Support Medical's ECAT Generation V Program....
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, identified as SPE2DB24D8001, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and runs through December 31, 2025. It is part of the DLA Troop Support Medical's ECAT Generation V Program, which seeks proposals for commercial medical equipment, accessories, consumables, and medical simulation...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, identified as SPE2DB24D8001, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract...
This federal contract award, SPE2DB24D8001, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that runs through December 31, 2025. It is part of the DLA Troop Support Medical's ECAT Generation V Program, which seeks proposals for commercial medical equipment, accessories, consumables, and medical simulation equipment...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBPZE, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $16,771.40 Firm Fixed Price Delivery Order contract is for the provision of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a performance period through November 7, 2023. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract award, identified as SPE2DB24D8001, is a $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of medical items to support U.S....
This federal contract award to Dakota Drug, Inc. was issued by the Defense Logistics Agency (DLA) to provide a variety of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract, identified as SPE2DB24D8001, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and is part of the DLA Troop Support Medical's ECAT Generation V Program. The contract has a performance period extending through December 31, 2025....
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZDT, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, primarily to support U.S. Armed Forces medical operations. The contract has a ceiling value of $1,528.94 and is a Firm Fixed Price Delivery Order. It is not associated with a set-aside program. Dakota...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a firm fixed price of $1,928.41 and a completion date of June 25, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA...
This federal contract award SPE2DB24D8001 was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $999,999,999.00 Indefinite Delivery Contract (IDC) is part of the DLA Troop Support Medical's ECAT Generation V Program and runs through December 31, 2025. Under this contract, Dakota Drug, Inc. will provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to...